diethyl p-acetylaminobenzylphosphonate | 118578-84-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: diethyl p-acetylaminobenzylphosphonate
• 英文别名: Diethyl 4-Acetamidobenzylphosphonate；N-[4-(diethoxyphosphorylmethyl)phenyl]acetamide
• CAS: 118578-84-0
• 化学式: C₁₃H₂₀NO₄P
• 分子量: 285.28
• InChiKey: LSQQRLOYPDMBGI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  19
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  64.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  烯丙基甲基碳酸酯 、 diethyl p-acetylaminobenzylphosphonate 在 silver hexafluoroantimonate 、 dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer 、 copper diacetate 、 silver carbonate 作用下， 以 1,4-二氧六环 为溶剂， 反应 24.0h， 以41%的产率得到diethyl (1-acetyl-2-methyl-1H-indol-5-yl)methylphosphonate
  参考文献：
  名称：

  Synthesis of indoles through Rh(III)-catalyzed C–H cross-coupling with allyl carbonates

  摘要：

  A practical Rh-catalyzed reaction was developed to achieve 2-alkyl-substituted indole synthesis. The reaction can tolerate a variety of synthetically important functional groups. The indole products can also be transformed into other important skeletons. Two bioactive compounds, that is indomethacin and pravadoline were prepared using the new method. (C) 2014 Published by Elsevier Ltd.

  DOI：

  10.1016/j.tetlet.2013.11.065
• 作为产物：
  描述：

  4-氨基苄基磷酸二乙酯 、 乙酸酐 在 4-二甲氨基吡啶 silica gel 作用下， 以 Pyridine methylene chloride 为溶剂， 反应 3.0h， 生成 diethyl p-acetylaminobenzylphosphonate
  参考文献：
  名称：

  Sirtuin related therapeutics and diagnostics for neurodegenerative diseases

  摘要：

  本文提供了调节sirtuin去乙酰化酶蛋白家族成员、p53活性、细胞和生物的凋亡、寿命和对压力的敏感性的方法和组合物。举例来说，方法包括使用激活化合物（如黄酮类、苯乙烯类、黄酮酮类、异黄酮类、儿茶素、查尔酮、单宁或花青素）或抑制化合物（如鞘脂类，例如鞘氨醇）与细胞接触。本文还公开了治疗、预防或诊断与神经元细胞死亡相关的疾病（例如神经退行性疾病）的方法。

  公开号：

  US20060025337A1

文献信息

• Palladium-catalyzed monoselective C–H borylation of acetanilides under acidic conditions
  作者：Bin Xiao、Yi-Ming Li、Zhao-Jing Liu、Han-Yi Yang、Yao Fu

  DOI：10.1039/c2cc31737k

  日期：——

  A practical Pd-catalyzed reaction was developed to achieve C–H activation/C–B cross-coupling of acetanilides under acidic conditions. The new reaction shows a good functional group tolerance and an exclusive mono-selectivity. This C–H borylation method may provide a generally applicable route for the conversion of C–H moieties into many other types of bonds.

  开发了一种实用的钯催化反应，以在酸性条件下实现乙酰苯胺的C–H活化/C–B交叉耦合。该新反应表现出良好的官能团耐受性和优异的单一选择性。这种C–H硼化方法可能为将C–H结构转化为多种其他类型的键提供了一种普遍适用的途径。
• Compositions for manipulating the lifespan and stress response of cells and organisms
  申请人：Sinclair A. David

  公开号：US20050096256A1

  公开（公告）日：2005-05-05

  Provided herein are methods and compositions for modulating the activity of sirtuin deacetylase protein family members; p53 activity; apoptosis; lifespan and sensitivity to stress of cells and organisms. Exemplary methods comprise contacting a cell with an activating compound, such as a flavone, stilbene, flavanone, isoflavone, catechin, chalcone, tannin or anthocyanidin; or an inhibitory compound, such as a sphingolipid, e.g., sphingosine.

  本文提供了调节sirtuin脱乙酰化酶蛋白家族成员、p53活性、细胞和生物的凋亡、寿命和对压力的敏感性的方法和组合物。示例方法包括将激活化合物（如黄酮类、stilbene、黄烷酮、异黄酮、儿茶素、查尔酮、单宁或花青素）或抑制化合物（如鞘脂类，例如鞘氨醇）与细胞接触。
• Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
  申请人：Sinclair A. David

  公开号：US20060025337A1

  公开（公告）日：2006-02-02

  Provided herein are methods and compositions for modulating the activity of sirtuin deacetylase protein family members; p53 activity; apoptosis; lifespan and sensitivity to stress of cells and organisms. Exemplary methods comprise contacting a cell with an activating compound, such as a flavone, stilbene, flavanone, isoflavone, catechin, chalcone, tannin or anthocyanidin; or an inhibitory compound, such as a sphingolipid, e.g., sphingosine. Also disclosed herein are methods for treating, preventing or diagnosing a disease associated with neuronal cell death, e.g., a neurodegenerative disease.

  本文提供了调节sirtuin去乙酰化酶蛋白家族成员、p53活性、细胞和生物的凋亡、寿命和对压力的敏感性的方法和组合物。举例来说，方法包括使用激活化合物（如黄酮类、苯乙烯类、黄酮酮类、异黄酮类、儿茶素、查尔酮、单宁或花青素）或抑制化合物（如鞘脂类，例如鞘氨醇）与细胞接触。本文还公开了治疗、预防或诊断与神经元细胞死亡相关的疾病（例如神经退行性疾病）的方法。
• Methods and compositions for treating flushing and drug induced weight gain
  申请人：Sinclair David

  公开号：US20060276416A1

  公开（公告）日：2006-12-07

  Provided herein are methods and compositions for treating and/or preventing flushing and/or weight gain. Methods may comprise modulating the activity or level of a sirtuin, such as SIRT1 or Sir2. Exemplary embodiments include methods and compositions for counteracting drug-induced weight gain and/or drug-induced flushing by administering a sirtuin-activating compound.

  本文提供了用于治疗和/或预防面部潮红和/或体重增加的方法和组合物。方法可以包括调节sirtuin的活性或水平，例如SIRT1或Sir2。示例实施方式包括通过给予sirtuin激活化合物来抵消药物引起的体重增加和/或药物引起的面部潮红的方法和组合物。
• Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
  申请人：Milburn Michael

  公开号：US20060276393A1

  公开（公告）日：2006-12-07

  Provided herein are methods and compositions for treating or preventing neurodegenerative disorders or blood coagulation disorders. Methods may comprise modulating the activity or level of a sirtuin, such as SIRT1 or Sir2. Exemplary methods comprise contacting a cell with a sirtuin activating compound, such as a flavone, stilbene, flavanone, isoflavone, catechin, chalcone, tannin or anthocyanidin; or an inhibitory compound, such as nicotinamide.

  本文提供了治疗或预防神经退行性疾病或血液凝固疾病的方法和组合物。方法可以包括调节sirtuin的活性或水平，例如SIRT1或Sir2。示例方法包括使用sirtuin激活化合物（例如黄酮，苯乙烯，黄烷酮，异黄酮，儿茶素，查尔酮，单宁或花青素）或抑制化合物（例如烟酰胺）与细胞接触。